Nothing Found
It seems we can't find what you're looking for. Perhaps searching can help.
It seems we can't find what you're looking for. Perhaps searching can help.
The US Food & Drug Administration (FDA) has communicated that it is exercising discretion to suspend enforcement of in-person dispensing requirements and in-person requirements related to the mifepristone Patient Agreement Form, provided other requirements are met.
To learn more about options for mail delivery to patients requiring mifepristone 200mg tablets, contact us.